Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$415M |
| 2 |
Eli Lilly
LLY
|
+$402M |
| 3 |
Goldman Sachs
GS
|
+$384M |
| 4 |
McDonald's
MCD
|
+$379M |
| 5 |
Tesla
TSLA
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.98B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 3 |
AT&T
T
|
+$460M |
| 4 |
Synchrony
SYF
|
+$398M |
| 5 |
Honeywell
HON
|
+$342M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.97% |
| 2 | Financials | 4.82% |
| 3 | Healthcare | 4.18% |
| 4 | Industrials | 3.64% |
| 5 | Consumer Discretionary | 3.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OXFD
4726
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $1.52M | ﹤0.01% |
88,303
+31,894
| +57% | +$505K |
|
|
NVTA
4727
CALL
DELISTED
Invitae Corporation
NVTA
| $1.52M | ﹤0.01% |
64,900
+19,400
| +43% | +$342K |
|
4728
Direxion Daily Small Cap Bear 3x ETF
TZA
$196M
| $1.52M | ﹤0.01% |
385
-725
| -65% | -$3.11M |
|
4729
Vipshop
VIPS
$6.81B
| $1.52M | ﹤0.01% |
189,015
-636,244
| -77% | -$4.51M |
|
4730
CALL
Flowserve
FLS
$10.3B
| $1.51M | ﹤0.01% |
33,500
+6,500
| +24% | +$284K |
|
|
HSKA
4731
DELISTED
Heska Corp
HSKA
| $1.51M | ﹤0.01% |
17,753
-4,084
| -19% | -$368K |
|
4732
CALL
BCE
BCE
$21.9B
| $1.51M | ﹤0.01% |
34,000
+5,100
| +18% | +$220K |
|
4733
Renasant Corp
RNST
$3.98B
| $1.51M | ﹤0.01% |
44,603
-11,359
| -20% | -$405K |
|
4734
PUT
Banco Santander
SAN
$210B
| $1.51M | ﹤0.01% |
339,861
+174,783
| +106% | +$797K |
|
4735
CALL
RenaissanceRe
RNR
$13.4B
| $1.51M | ﹤0.01% |
10,500
-2,100
| -17% | -$294K |
|
|
TUP
4736
CALL
DELISTED
Tupperware Brands Corporation
TUP
| $1.51M | ﹤0.01% |
58,900
-14,600
| -20% | -$446K |
|
4737
Berkshire Hathaway Class A
BRK.A
$1.08T
| $1.51M | ﹤0.01% |
+5
| New | +$1.51M |
|
|
NVRO
4738
CALL
DELISTED
NEVRO CORP.
NVRO
| $1.51M | ﹤0.01% |
24,100
-200
| -0.8% | -$9.4K |
|
|
AIMT
4739
CALL
DELISTED
Aimmune Therapeutics
AIMT
| $1.51M | ﹤0.01% |
67,400
+9,900
| +17% | +$233K |
|
4740
PUT
Medifast
MED
$128M
| $1.5M | ﹤0.01% |
11,800
-5,000
| -30% | -$634K |
|
4741
PUT
Vanguard Morningstar Total Stock Market ETF
VTI
$695B
| $1.5M | ﹤0.01% |
10,400
-13,200
| -56% | -$1.84M |
|
4742
Intellia Therapeutics
NTLA
$1.67B
| $1.5M | ﹤0.01% |
88,104
+62,159
| +240% | +$927K |
|
4743
Univest Financial
UVSP
$1.19B
| $1.5M | ﹤0.01% |
61,480
-19,898
| -24% | -$486K |
|
|
HDS
4744
PUT
DELISTED
HD Supply Holdings, Inc.
HDS
| $1.5M | ﹤0.01% |
34,600
+7,400
| +27% | +$308K |
|
4745
CALL
Fossil Group
FOSL
$329M
| $1.5M | ﹤0.01% |
109,100
-168,200
| -61% | -$2.68M |
|
4746
CALL
Rayonier Advanced Materials
RYAM
$570M
| $1.5M | ﹤0.01% |
110,400
+85,200
| +338% | +$1.15M |
|
4747
Vanguard Total World Bond ETF
BNDW
$1.89B
| $1.49M | ﹤0.01% |
+19,435
| New | +$1.47M |
|
4748
CALL
EPR Properties
EPR
$4.69B
| $1.49M | ﹤0.01% |
19,400
-3,300
| -15% | -$240K |
|
|
ODP
4749
DELISTED
ODP
ODP
| $1.49M | ﹤0.01% |
41,101
-64,859
| -61% | -$2.08M |
|
|
AMED
4750
CALL
DELISTED
Amedisys
AMED
| $1.49M | ﹤0.01% |
12,100
-13,200
| -52% | -$1.66M |
|
Similar funds
Ken Griffin's Q1 2019 Portfolio in Review
As of Q1 2019, Ken Griffin held 10,449 positions worth $201B, up 10% from $183B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ken Griffin withdrew a net $13B in Q1 2019, closing 1,251 positions and reducing 3,810 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $223M position sold in full.
By sector, the portfolio is most concentrated in Technology at 6% of assets, up from 4.8% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ken Griffin opened a new position in Elanco Animal Health worth $251M.
- Ken Griffin's largest Q1 2019 buy was Elanco Animal Health: 7,832,197 shares worth $251M.
- Ken Griffin added most to Walt Disney in Q1 2019, an estimated $415M increase.
- Ken Griffin's biggest Q1 2019 reduction was Amazon, cutting an estimated $1.98B.
- Ken Griffin fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $223M.
- Ken Griffin's ten largest holdings make up 24% of its $201B portfolio in Q1 2019.
- Ken Griffin opened 1,429 new positions and closed 1,251 in Q1 2019.
- Ken Griffin's portfolio value rose 10% quarter-over-quarter to $201B.
Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.